Extended - duration treatment of superficial vein thrombosis of the lower limbs with tinzaparin
Abstract
PURPOSE: To identify risk factors for recurrent thromboembolic events (RTEs) and define the optimum duration of treatment with tinzaparin in patients with superficial vein thrombosis (SVT) of the lower limbs.MATERIAL AND METHODS: A total of 147 consecutive patients with significant SVT, treated with subcutaneously administered tinzaparin. The composite primary endpoint of the study was RTE, deep-vein thrombosis (DVT) and/or pulmonary embolism (PE) at 120 days. Patients were stratified into group A, where patients received a variable dose of tinzaparin for up to 60 days (n=98), and a subsequent group B-ext, where patients received a standardized intermediate dose of tinzaparin (n=49) for 90 days. RESULTS: RTEs occurred in 15/147 patients (10.2%), including recurrent SVT (n=10), DVT (n=4) and fatal PE (n=1). RTEs were less frequent in group B-ext (0% versus 15.3% for group A, p=0.004), a difference that remained significant at the one-year follow-up. Clinically extensive SVT was an indep ...
show more
Download full text in PDF format (2.46 MB)
(Available only to registered users)
|
All items in National Archive of Phd theses are protected by copyright.
|
Usage statistics
VIEWS
Concern the unique Ph.D. Thesis' views for the period 07/2018 - 07/2023.
Source: Google Analytics.
Source: Google Analytics.
ONLINE READER
Concern the online reader's opening for the period 07/2018 - 07/2023.
Source: Google Analytics.
Source: Google Analytics.
DOWNLOADS
Concern all downloads of this Ph.D. Thesis' digital file.
Source: National Archive of Ph.D. Theses.
Source: National Archive of Ph.D. Theses.
USERS
Concern all registered users of National Archive of Ph.D. Theses who have interacted with this Ph.D. Thesis. Mostly, it concerns downloads.
Source: National Archive of Ph.D. Theses.
Source: National Archive of Ph.D. Theses.